Erytech Pharma has submitted a centralized Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for Graspa/Ery-Asp (human erythrocytes...
Pigment epithelial detachment (PED), the anatomical separation of the retinal pigment epithelium from the Bruch membrane, is common in many chorioretinal diseases, including neovascular age-related macular degeneration.
Merck Inc.,announced topline results from the pivotal PNEU-PED (V114-029) study evaluating the immunogenicity, safety and tolerability of Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine) in healthy infants enrolled between 42-90 days of age (n=1720).
Arcutis Biotherapeutics, Inc. announced the enrollment of the last subject in the INTEGUMENT-PED Pivotal Phase III trial evaluating roflumilast cream 0.05% for the treatment of mild to moderate AD in children ages 2 to 5
Johnson & Johnson announced that the FDA has approved Edurant Ped (rilpivirine) for the treatment of HIV-1 in combination with other antiretroviral therapies (ARVs) in treatment-naïve children (with HIV-1 RNA <100,000 copies ml) at least 2 years of age and weighing at least 14 kg and less than 25 kg.>100,000>
Arcutis Biotherapeutics, Inc., presented in a late-breaking clinical trial session at the American Academy of Dermatology (AAD) annual meeting (San Diego, CA, March 8 – 12) new data from its INTEGUMENT-PED pivotal Phase III study of investigational roflumilast cream 0.05% in children 2 to 5 years of age with mild to moderate atopic dermatitis